GBA1 and Parkinson disease: There is a crucial delineation between ‘pathogenic’ GBA variants (such as those causing GD in a compound heterozygous/homozygous carrier state) and ‘PD risk factor’ GBA variants, which show an association with PD risk but are not considered causative for GD (Skrahina et al. 2020).